Eli Lilly partners with Walmart to sell weight loss drug directly to patients nationwide

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

Eli Lilly’s stock jumps as Zepbound sales nearly triple at lower prices

Eli Lilly’s stock rallies, as Zepbound sales nearly tripled, leading to record revenue and a raised full-year outlook.
ConsumerAffairs

LillyDirect and Walmart team up to make Zepbound easier to access

The partnership between LillyDirect and Walmart allows patients to pick up Zepbound at Walmart pharmacies at the same self-pay price as online. Sel ...
Fierce Pharma

Lilly's Zepbound, Mounjaro show out with $10B quarter despite CVS formulary hitch

Worth noting, CVS Caremark—the biggest PBM in the U.S.— announced in May that it would make Novo Nordisk’s rival drug Wegovy ...

This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?

Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them is Pfizer; in September that company announced it would acquire Metsera, a ...
Everyday Health on MSN

Walmart to Offer Discounted GLP-1 Drugs, Following Costco, Sam’s Club, and CVS

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...
BioSpace

Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3

Together, Mounjaro and Zepbound brought in $11.98 billion in the third quarter even with price decreases for the medicines.

Eli Lilly, Walmart partner to bring Zepbound to customers with direct-to-consumer pricing

Eli Lilly and Company and Walmart have announced a partnership to offer Zepbound single-dose vials at Walmart pharmacies. The ...